Dr. Biernacka is a board-certified anatomic pathologist and cytopathologist with expertise in breast pathology. She works closely with other members of the Multidisciplinary Breast Program at the University of Chicago, providing comprehensive and coordinated care to breast cancer patients. Her clinical and research interests center on the morphologic and molecular features of breast diseases, with a special focus on apocrine lesions and androgen receptor signaling in breast cancer.
Massachusetts General Hospital
Fellowship - Breast Pathology
2017
Dartmouth-Hitchcock
Fellowship - Cytopathology
2016
Baylor College of Medicine
Residency - Anatomic Pathology
2015
The Medical University of Lodz
Poland
PhD
2012
Albert Einstein College of Medicine
Postdoctoral Fellowship
2012
Anderson Cancer Center
MD
2010
The Medical University of Lodz
Poland
MD
2006
Standardized Upstream Processing of Ovarian Cancer Surgical Specimens for TIL-Oriented Cellular Workflows.
Standardized Upstream Processing of Ovarian Cancer Surgical Specimens for TIL-Oriented Cellular Workflows. Cancers (Basel). 2026 Sep 18; 18(18).
PMID: 42794994
Hematolymphoid neoplasms involving the breast: A single institution clinicopathologic study of 59 patients.
Hematolymphoid neoplasms involving the breast: A single institution clinicopathologic study of 59 patients. Ann Hematol. 2026 Apr 10; 105(5).
PMID: 41957230
Remodeling of the cell membrane-associated protein pool affects adhesive membrane properties in filaggrin insufficient keratinocytes and impacts distinct cellular and organellar functions.
Remodeling of the cell membrane-associated protein pool affects adhesive membrane properties in filaggrin insufficient keratinocytes and impacts distinct cellular and organellar functions. BMC Biol. 2026 01 08; 24(1):30.
PMID: 41507905
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy.
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy. J Appl Clin Med Phys. 2026 Jan; 27(1):e70439.
PMID: 41456332
Transformations in river water chemistry following wastewater treatment implementation in a mountain region of the Polish Carpathians.
Transformations in river water chemistry following wastewater treatment implementation in a mountain region of the Polish Carpathians. Environ Sci Pollut Res Int. 2025 Nov; 32(55):30580-30595.
PMID: 41389126
Transformation of water chemistry in the Stara River under climate and land use changes in the Carpathians.
Transformation of water chemistry in the Stara River under climate and land use changes in the Carpathians. Sci Rep. 2025 Oct 02; 15(1):34463.
PMID: 41039006
Risk of malignancy associated with indeterminate categories in the Milan System for reporting pediatric salivary gland cytopathology: a multi-institutional study.
Risk of malignancy associated with indeterminate categories in the Milan System for reporting pediatric salivary gland cytopathology: a multi-institutional study. J Am Soc Cytopathol. 2026 Jan-Feb; 15(1):39-45.
PMID: 40781025
Primary Melanoma of the Lung: A Vanishing Entity.
Primary Melanoma of the Lung: A Vanishing Entity. Acta Cytol. 2025; 69(4):361-366.
PMID: 40373758
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration.
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration. Breast Cancer Res Treat. 2025 Feb; 209(3):563-572.
PMID: 39579248
Fate of nondiagnostic thyroid fine needle aspirations.
Fate of nondiagnostic thyroid fine needle aspirations. Diagn Cytopathol. 2024 Dec; 52(12):709-714.
PMID: 39051543